Minzhang Chen

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

New Delhi, March 04, 2022: WuXi STA – a subsidiary of WuXi AppTec – today announced that its drug product…

3 years ago

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

State-of-the-art facility expands WuXi STA's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial …

5 years ago

WuXi STA forms Strategic Partnership with Beta Pharma

STA will accelerate process R&D and manufacturing of late phase and commercial targets New Delhi, March 25, 2019: STA Pharmaceutical…

6 years ago

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA. Shanghai, May 03, 2018: STA…

7 years ago